Skip to main content

SANUWAVE Health, Inc.

corporate_fare Company Profile

SANUWAVE Health, Inc.

SNWV·NASDAQ·Industrial Applications And Services·CIK 0001417663

Sanuwave is a medical device company that provides directed energy products for wound care. The company focuses on regenerative medicine, using noninvasive ultrasound to promote tissue, musculoskeletal, and vascular repair and regeneration. Sanuwave's primary product is the UltraMIST® system, which is patented and FDA cleared. This system treats various acute and chronic wounds. The company holds an intellectual property portfolio of over 60 patents. In the year ended December 31, 2025, Sanuwave reported total revenues of $44.1 million, a 35% increase from $32.6 million in the year ended December 31, 2024. UltraMIST systems and consumables accounted for approximately 99% of 2025 revenues, compared to 98% of revenues in 2024. The UltraMIST system is the only commercial product currently marketed by the company. It delivers low-frequency, non-thermal ultrasound to target tissues using a fluid mist, transmitting energy in a non-contact manner. This energy penetrates wound beds to promote healing, reduce inflammation, kill bacteria and biofilms, and increase blood vessel growth in and around the wound. The FDA has cleared UltraMIST for wound healing and debridement for various acute and chronic wounds, including diabetic foot ulcers, venous leg ulcers, split thickness wounds/skin grafts, deep tissue pressure injuries, and surgical wounds. The UltraMIST system is cleared for marketing in the U.S. by the FDA (K140782) and has Centers for Medicare and Medicaid Services (CMS) category one reimbursement under code 97610. A healthcare professional must administer the UltraMIST system treatment.

SANUWAVE Health, Inc. (NASDAQ:SNWV) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for SNWV at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • SANUWAVE Health Declares Non-Reliance on Past Financials, Plans Restatement Due to Tax Liabilities

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$44.05M
Net Income
$11.81M
Diluted EPS
$0.41
Op. Cash Flow
$3.88M
Free Cash Flow
$1.93M
Gross Profit
$33.97M
Operating Income
$4.95M
Cash & Equivalents
$11.96M
Total Debt
$21.89M
Debt / Equity
13.52×
Net Margin
26.8%
Shares Outstanding
8.59M sh
Source: 10-K · filed 2026-03-26 · accession 0001628280-26-021443
$1.58 -0.63% today
52-week range · as of 2026-11-10 $1.58 – $36.2
Market cap
$12.9M
Volume
57.7K (0.5× avg)
3-mo avg 108K
Live data · 2026-11-22 12:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SNWV - Filings & News (Page 2)

SNWV
Mar 13, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $20.69
Real-time Price: $1.58 info
Change: -$19.11 (-92%) info
Market Cap: $12.903M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets